# The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)

> **NCT07151391** · PHASE2 · RECRUITING · sponsor: **University of Utah** · enrollment: 86 (estimated)

## Conditions studied

- Neuroendocrine Tumors
- Gynecologic Cancer

## Interventions

- **DRUG:** Guarana
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07151391
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-03
- **Primary completion:** 2027-09
- **Final completion:** 2028-09
- **Target enrollment:** 86 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07151391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07151391, "The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07151391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*